A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 8201642.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a prospective, comparative study 68 men were treated for hot flushes after androgen deprivation therapy for prostate cancer. Complete responses (elimination of hot flushes) were rare in patients receiving either combined phenobarbital plus ergotamine or clonidine. Of the men receiving either diethylstilbestrol or megestrol acetate 70% had a complete response, while another 20% had a greater than 50% decrease in the severity of hot flushes. Based upon a lower incidence of side effects, oral megestrol acetate was the preferred treatment for hot flushes in this study.
Medical subject headings
- Clonidine
- Diethylstilbestrol
- Ergotamine
- Flushing
- Megestrol
- Phenobarbital
- Prostatic Neoplasms